Antidote’s insights from 7,000+ type 2 diabetes patients [one-pager]

Having a deep understanding of the patient population is key to successful recruiting for clinical trials — which is why Antidote takes discovering patient insights seriously.

To better understand the type 2 diabetes (T2D) population, we recently analyzed a data set of over 7,000 opted-in patients with a variety of demographic backgrounds. We found out key information like average BMI, average HbA1c, and rates of comorbidities — download the one-pager today to see what we learned.

‍